Advertisement

Antiproliferative Effects of Probiotics

  • Tejinder Kaur
  • Praveen P. Balgir
Chapter

Abstract

Probiotics are defined as live microorganisms that confer health benefits on the host when consumed in adequate amounts. They maintain proper microbial balance in gastrointestinal tract by strain-specific health-promoting activities like their antimicrobial, immunomodulation, anti-inflammatory, and anticarcinogenic attributes. A number of reports on anticarcinogenic effects exerted by probiotics against various types of cancer are available in literature. The anticarcinogenic properties of probiotics have been reported in various cancers and are attributable to a number of mechanisms at molecular level. The mechanisms underlying anti-cancerous effect include enhanced immune response in host, probiotic binding of potential carcinogens and their degradation, changes in the intestinal microflora, secretion of antitumorigenic compounds by probiotics in the colon leading to metabolic changes of colonic microflora, alteration in physicochemical environment of the colon, etc. The studies have been reviewed as to the in vivo and in vitro mechanisms underlying the antiproliferative effects exerted by probiotic lactic acid bacteria (LABs). However, for the therapy to reach the clinic, research in larger datasets needs to be carried out taking into consideration strain specificity of the effective probiotic or derivatives and their effect on the microbiome of the patients along with envisaged side effects. Further to establish the precise mechanisms by which LAB and its various entities inhibit cancer, carefully designed epidemiological studies are required. It purports to be a field which can yield novel drug entities with few or no side effects.

Notes

Acknowledgement

This work was supported by grant from the DBT-Punjabi University Interdisciplinary Life Science Programme for advanced research and education (DBT-IPLS Project) No. BT/PR-4548/INF/22/146/2012. and ICMR, New Delhi for Senior Research Fellowship to Ms. Tejinder Kaur.

References

  1. Baricault L, Denariaz G, Houri JJ, Bouley C, Sapin C, Trugnan G (1995) Use of HT-29, a cultured human colon cancer cell line, to study the effect of fermented milks on colon cancer cell growth and differentiation. Carcinogenesis 16:245–252CrossRefPubMedGoogle Scholar
  2. Biasco G, Paganelli GM, Brandi G, Brillanti S et al (1991) Effect of Lactobacillus acidophilus and Bifidobacterium bifidum on rectal cell kinetics and fecal pH. Ital J Gastroenterol 23:142PubMedGoogle Scholar
  3. Burns A, Rowland I (2000) Anti-carcinogenicity of probiotics and prebiotics. Curr Issues Intest Microbiol 1:13–24PubMedGoogle Scholar
  4. Chang JH, Shim YY, Cha SK, Chee KM (2010) Probiotic characteristics of lactic acid bacteria isolated from kimchi. J Appl Microbiol 109:220–230CrossRefPubMedGoogle Scholar
  5. Commane D, Hughes R, Shortt C, Rowland I (2005) The potential mechanisms involved in the anti-carcinogenic action of probiotics. Mutat Res 591:276–289CrossRefPubMedGoogle Scholar
  6. Cornut G, Fortin C, Denis Soulieres D (2008) Antineoplastic properties of bacteriocins: revisiting potential active agents. Am J Clin Oncol 31:399–404CrossRefPubMedGoogle Scholar
  7. De Simone C, Vesely R, Bianchi Salvadori B, Jirillo E (1993) The role of probiotics in modulation of the immune system in man and in animals. Int J Immunother 9:23–28Google Scholar
  8. Dimitrovski D, Cenci A, Winkelhausen E, Langerholc T (2014) Lactobacillus plantarum extracellular metabolites: in vitro assessment of probiotic effects on normal and cancerogenic human cells. Int Dairy J 39:293–300CrossRefGoogle Scholar
  9. Duhan JS, Nehra K, Gahlawat SK et al (2013) Bacteriocins from lactic acid bacteria. Salar RK, Gahlawat SK, Siwach P, Duhan JS Biotechnology: prospects and applications, Springer, New Delhi, 127–142. isbn:978-81-322-1682-7.  https://doi.org/10.1007/978-81-322-1683-4 CrossRefGoogle Scholar
  10. FAO/WHO (2002) Guidelines for the evaluation of probiotics in food. Joint FAO/WHO working group report on drafting guide lines for the evaluation of probiotics in food London, Ontario, CanadaGoogle Scholar
  11. Friend BA, Farmer RE, Shahani KM (1982) Effect of feeding and intraperitoneal implantation of yogurt culture cells on Ehrlich ascites tumor. Milch Wiss 37:708–710Google Scholar
  12. Geier MS, Butler RN, Howarth GS (2006) Probiotics, prebiotics and synbiotics, a role in chemoprevention of colorectal cancer. Cancer Biol Ther 5:1265–1269CrossRefPubMedGoogle Scholar
  13. Goldin BR, Gorbach SL (1980) Effect of Lactobacillus acidophilus dietary supplements on 1, 2-dimethylhydrazine dihydrochloride-induced intestinal cancer in rats. J Natl Cancer Inst 64:263–265CrossRefPubMedGoogle Scholar
  14. Grimoud J, Durand H, de Souza S, Monsan P et al (2010) In vitro screening of probiotics and synbiotics according to anti-inflammatory and anti-proliferative effects. Int J Food Microbiol 144:42–50CrossRefPubMedGoogle Scholar
  15. Hassan M, Kjos M, Nes IF et al (2012) Natural antimicrobial peptides from bacteria: characteristics and potential applications to fight against antibiotic resistance. J Appl Microbiol 113(4):723–736CrossRefPubMedGoogle Scholar
  16. Hayatsu H, Hayatsu T (1993) Suppressing effect of Lactobacillus casei administration on the urinary mutagenicity arising from ingestion of fried ground beef in the human. Cancer Lett 73:173–179CrossRefPubMedGoogle Scholar
  17. Hirayama K, Rafter J (2000) The role of probiotic bacteria in cancer prevention. Microbes Infect 2(6):681–686CrossRefPubMedGoogle Scholar
  18. Iyer C, Kosters A, Sethi G, Kunnumakkara AB et al (2008) Probiotic Lactobacillus reuteri promotes TNF-induced apoptosis in human myeloid leukemia-derived cells by modulation of NF-kB and MAPK signaling. Cell Microbiol 10(7):1442–1452CrossRefPubMedGoogle Scholar
  19. Kahouli I, Malhotra M, Alaoui-Jamali M, Prakash S (2015) In vitro characterization of the anti-cancer activity of the probiotic bacterium Lactobacillus fermentum NCIMB 5221 and potential against colorectal cancer. J Cancer Sci Ther 7:224–235Google Scholar
  20. Kailasapathy K, Chin J (2000) Survival and therapeutic potential of probiotic organisms with reference to Lactobacillus acidophilus and Bifidobacterium spp. Immunol Cell Biol 78:80–88CrossRefPubMedGoogle Scholar
  21. Kato I, Kobayashi S, Yokokura T, Mutai M (1981) Antitumor activity of Lactobacillus casei in mice. Gann 72:517–523PubMedGoogle Scholar
  22. Kohwi Y, Imai K, Tamura Z, Hashimoto Y (1978) Antitumor effect of Bifidobacterium infantis in mice. Gann 69:613–618Google Scholar
  23. Kumar B, Balgir PP, Kaur B et al (2012a) In vitro cytotoxicity of native and rec-pediocin CP2 against cancer cell lines: a comparative study. Pharm Anal Acta 3:8CrossRefGoogle Scholar
  24. Kumar RS, Kanmani P, Yuvaraj N, Paari KA et al (2012b) Lactobacillus plantarum AS1 isolated from South Indian fermented food Kallappamn suppress 1,2-dimethyl hydrazine (DMH)-induced colorectal cancer in male Wistar rats. Appl Biochem Biotechnol 166:620–631CrossRefPubMedGoogle Scholar
  25. Lee JW, Shin JG, Kim EH, Kang HE et al (2004) Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum. J Vet Sci 5(1):41–48PubMedGoogle Scholar
  26. Lee DK, Jang S, Kim MJ et al (2008) Anti-proliferative effects of Bifidobacterium adolescentis SPM0212 extract on human colon cancer cell lines. BMC Cancer 8:310CrossRefPubMedPubMedCentralGoogle Scholar
  27. Li W, Ji J, Tang W, Rui X et al (2014) Characterization of an antiproliferative exopolysaccharide (LHEPS-2) from Lactobacillus helveticus MB2-1. Carbohydr Polym 105:334–340CrossRefPubMedGoogle Scholar
  28. Lidbeck A, Geltner-Allinger U, Orrhage KM, Ottava L, Brismar B, Gustafsson JA, Rafter JJ, Nord CE (1991) Impact of Lactobacillus acidophilus supplements on the faecal microflora and soluble faecal bile acids in colon cancer patients. Microb Ecol Health Dis 4:81–88CrossRefGoogle Scholar
  29. Lidbeck A, Overvik E, Rafter J et al (1992) Effect of Lactobacillus acidophilus supplements on mutagen excretion in feces and urine in humans. Microb Ecol Health Dis 5:59–67CrossRefGoogle Scholar
  30. Lindner DJD, Pandey A, Thomaz-Soccol V (2010) The potential of probiotics: a review. Food Technol Biotechnol 48:413–434Google Scholar
  31. Marteau P, Pochart P, Flourie B, Pellier P et al (1990) Effect of chronic ingestion of a fermented dairy product containing Lactobacillus acidophilus and Bifidobacterium bifidum on metabolic activities of the colonic flora in humans. Am J Clin Nutr 52:685–688CrossRefPubMedGoogle Scholar
  32. O’Mahony L, Feeney M, O’Halloran S, Murphy L et al (2001) Probiotic impact on microbial flora, inflammation and tumour development in IL10 knockout mice. Aliment Pharm Therap 15:1219–1225CrossRefGoogle Scholar
  33. Oelschlaeger TA (2010) Mechanisms of probiotic actions-a review. Int J Med Microbiol 300:57–62CrossRefGoogle Scholar
  34. Pessi T, SuTas Y, Saxelin M et al (1999) Antiproliferative effects of homogenates derived from five strains of candidate probiotic bacteria. Appl Environ Microbiol 65(11):4725–4728PubMedPubMedCentralGoogle Scholar
  35. Rowland IR, Rumney CJ, Coutts JT, Lievense LC (1998) Effect of Bifidobacterium longum and inulin on gut bacteria metabolism and carcinogen-induced aberrant crypt foci in rats. Carcinogenesis 19:281–285CrossRefPubMedGoogle Scholar
  36. Sadeghi-Aliabadi H, Mohammadi F, Fazeli H, Mirlohi M (2014) Effects of Lactobacillus plantarum A7 with probiotic potential on colon cancer and normal cells proliferation in comparison with a commercial strain. Iran J Basic Med Sci 17:815–819PubMedPubMedCentralGoogle Scholar
  37. Schiffrin EJ, Rochat F, Link-Amster H, Aeschlimann JM, Donnet-Hughes A (1995) Immunomodulation of human blood cells following the ingestion of lactic acid bacteria. J Dairy Sci 78:491–496CrossRefPubMedGoogle Scholar
  38. Shahani KM, Ayebo AD (1980) Role of dietary lactobacilli in gastrointestinal microecology. Am J Clin Nutr 33:2448–2457CrossRefPubMedGoogle Scholar
  39. Singh J, Rivenson A, Tomita M, Shimamura S, Ishibashi N, Reddy BS (1997) Bifidobacterium longum, a lactic acid producing intestinal bacterium inhibits colon cancer and modulates the intermediate biomarkers of colon carcinogenesis. Carcinogenesis 18:833–841CrossRefPubMedGoogle Scholar
  40. Sun J, Shi YH, Le GW, Ma XY (2005) Distinct immune response induced by peptidoglycan derived from Lactobacillus sp. World J Gastroenterol 11:6330–6337CrossRefPubMedPubMedCentralGoogle Scholar
  41. Tiptiri-Kourpeti A, Spyridopoulou K, Santarmaki V et al (2016) Lactobacillus casei exerts anti-proliferative effects accompanied by apoptotic cell death and up-regulation of TRAIL in colon carcinoma cells. PLoS One 11(2):e0147960CrossRefPubMedPubMedCentralGoogle Scholar
  42. Wang K, Li W, Rui X, Chen X et al (2014) Characterization of a novel exopolysaccharide with antitumor activity from Lactobacillus plantarum 70810. Int J Biol Macromol 63:133–139CrossRefPubMedGoogle Scholar
  43. Zhang XB, Ohta Y (1993) Microorganisms in the gastrointestinal tract of the rat prevent absorption of the mutagen carcinogen 3-amino-1,4-dimethyl-5H-pyrido[4,3-b]indole. Can J Microbiol 39:841–845CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2018

Authors and Affiliations

  • Tejinder Kaur
    • 1
  • Praveen P. Balgir
    • 1
  1. 1.Department of BiotechnologyPunjabi UniversityPatialaIndia

Personalised recommendations